• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[转移性乳腺癌的化疗]

[Chemotherapy of metastasizing breast cancer].

作者信息

Wascher H

出版信息

Wien Med Wochenschr. 1985 Dec 31;135(23-24):590-4.

PMID:3841627
Abstract

Treatment strategies for metastatic breast cancer are determined by various prognostic factors. The main two factors are if the patients are of high or low risk. Primary treatment consists of combinations of various drugs with (VAC) or without adriamycin (CMF). Advantages, disadvantages and side effects of these treatment regimens of those (above) as well as other treatment strategies are being discussed.

摘要

转移性乳腺癌的治疗策略由多种预后因素决定。主要的两个因素是患者风险高低。初始治疗包括多种药物联合（VAC）或不联合阿霉素（CMF）。正在讨论上述这些治疗方案以及其他治疗策略的优缺点和副作用。

相似文献

1
[Chemotherapy of metastasizing breast cancer].[转移性乳腺癌的化疗]
Wien Med Wochenschr. 1985 Dec 31;135(23-24):590-4.
2
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.采用环磷酰胺、甲氨蝶呤和氟尿嘧啶辅助化疗治疗的20多年来淋巴结阳性原发性乳腺癌的自然病史：癌症与白血病B组的一项研究
J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006.
3
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.一项随机试验，比较环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）与交替使用CMF、表柔比星和长春新碱作为可手术乳腺癌的一线化疗方案。
Cancer. 2002 Jul 15;95(2):228-35. doi: 10.1002/cncr.10678.
4
On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.
Wien Klin Wochenschr. 1986 Dec 5;98(23):790-7.
5
[Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer].[细胞生长抑素、阿霉素和长春新碱联合作为转移性乳腺癌二线治疗的疗效及毒副作用]
Arch Geschwulstforsch. 1989;59(5):341-6.
6
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.米托蒽醌、5-氟尿嘧啶和高剂量亚叶酸钙（NFL）与静脉注射环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）用于转移性乳腺癌患者一线化疗的比较：一项随机II期试验。
Cancer. 1997 Feb 15;79(4):740-8.
7
[Treatment of metastatic breast cancer].[转移性乳腺癌的治疗]
Harefuah. 1986 Jul;111(1-2):8-11.
8
[Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Zentralbl Chir. 1998;123 Suppl 5:156-8.
9
[Therapeutic results and toxic side effects of the cytostasan, adriamycin and vincristine combination as second line therapy in metastatic breast cancer].[细胞生长抑素、阿霉素和长春新碱联合作为转移性乳腺癌二线治疗的疗效及毒副作用]
Geburtshilfe Frauenheilkd. 1991 May;51(5):383-6. doi: 10.1055/s-2007-1026163.
10
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.口服尿嘧啶和替加氟与经典的环磷酰胺、甲氨蝶呤、氟尿嘧啶相比，用于淋巴结阴性、高危乳腺癌患者术后化疗：国家乳腺癌辅助治疗研究01试验
J Clin Oncol. 2009 Mar 20;27(9):1368-74. doi: 10.1200/JCO.2008.18.3939. Epub 2009 Feb 9.